KCNK9 and breast carcinoma: TASK3 is overexpressed in >40% of breast cancers, but genomic amplification of KCNK9 is reported to occur in <10% of breast cancers [24], indicating that epigenetic mechanisms may play a key role in TASK3 overexpression.